Low-dose aspirin for primary and secondary prevention of cardiovascular events in Denmark 1998–2018

Low-dose aspirin for primary and secondary prevention of cardiovascular events in Denmark 1998–2018

Abstract Randomised controlled trials have shown a neutral or even unfavourable risk–benefit balance of aspirin for primary prevention of cardiovascular events. Using Danish nationwide registries, we investigated aspirin use and associated risks during the past two decades (1998–2018). We linked ind...

Full description

Bibliographic Details
Main Authors: Mikkel B. Christensen, Espen Jimenez-Solem, Martin. T. Ernst, Morten Schmidt, Anton Pottegård, Erik L. Grove
Format: Article
Language:English
Published: Nature Publishing Group 2021-06-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-021-93179-8

Similar Items

Similar Items